Discontinued — last reported Q2 '23

Business Segments · Amortization

Consumer — Amortization

Johnson & Johnson Consumer — Amortization remained flat by 0.0% to $100.00M in Q2 2023 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $100.00M to $100.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2018
Last reportedQ2 2023

How to read this metric

High amortization levels often reflect significant past acquisition activity, impacting reported net income without affecting cash flow.

Detailed definition

This represents the non-cash expense related to the systematic write-down of intangible assets, such as patents or trade...

Peer comparison

Standard accounting disclosure for companies with significant intangible assets from M&A.

Metric ID: jnj_segment_consumer_health_amortization

Historical Data

7 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23
Value$100.00M$100.00M$100.00M$100.00M$100.00M$100.00M$100.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%
Range$100.00M$100.00M
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak6+ quarters growth

Frequently Asked Questions

What is Johnson & Johnson's consumer — amortization?
Johnson & Johnson (JNJ) reported consumer — amortization of $100.00M in Q2 2023.
How has Johnson & Johnson's consumer — amortization changed year-over-year?
Johnson & Johnson's consumer — amortization decreased by 0.0% year-over-year, from $100.00M to $100.00M.
What does consumer — amortization mean?
The non-cash expense for the gradual write-down of intangible assets in the Consumer Health segment.